Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Arundic acid

Drug Profile

Arundic acid

Alternative Names: Arocyte Injection; Cereact Capsule; MK-0724; ONO-2506; ONO-2506PO; Proglia®

Latest Information Update: 18 Mar 2010

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Ono Pharmaceutical
  • Developer Merck & Co; Ono Pharmaceutical
  • Class Neuroprotectants; Nootropics; Octanoic acids; Small molecules
  • Mechanism of Action Astrocyte modulators; Cyclo-oxygenase 2 inhibitors; Free radical scavengers; Nitric oxide synthase type II inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Alzheimer's disease; Amyotrophic lateral sclerosis; Parkinson's disease; Stroke

Most Recent Events

  • 01 Nov 2006 This compound is still in active development for Alzheimer's disease in Japan
  • 01 Nov 2006 Data presented at the 36th Annual Meeting of the Society for Neuroscience (SfN-2006) have been added to the Alzheimer's disease pharmacodynamics section
  • 18 Aug 2006 Commencement of phase-II clinical trials in Stroke planned in North America (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top